Study to Evaluate the Safety, Tolerability, and Action of AMG 357 in Females With Rheumatoid Arthritis
NCT02499315
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
32
Enrollment
INDUSTRY
Sponsor class
Stopped
Study has stopped due to a decision by Amgen to terminate the program
Conditions
Rheumatoid Arthritis
Interventions
DRUG:
AMG 357
DRUG:
Placebo
Sponsor
Amgen